Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

China
Obesity
AI
Drug Pricing
Cell & Gene Therapies

Business

Deals
Financing
Earnings
Commercial Strategy
Approvals & Launches
Trial Results
Market Access

Disease

Cancer
Immune Disorders
Cardiovascular
Neurological
Rare Diseases

Deep Dives

Interviews
Data Insights
Scrip Asks
Disease Landscapes

Focus On Asia

Japan
South Korea
India
Scrip Asia 100

Tools & Trackers

Pipeline Watch
Finance Watch
Deal Watch
Stock Watch
Top Selling Drugs
Company Rankings
Executive Moves

Conference Coverage

Partner Insights

Scrip Perspectives

Previewing biopharma commercial, market access and development themes.

Medtech Insight

Generics Bulletin

AstraZeneca, Eli Lilly and Cancer Dominate 2016 EU New Drug Approvals

Jan 12 2017

• By Ian Schofield

Biopharma In Perspective 2016-2017

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

Additional Topics

Europe Approvals Cancer BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Scrip Perspectives
Scrip 100 Ranking
Scrip Asia 100
Conferences
Executives On The Move
Pipeline Watch

Terms and Conditions Opens in new window

Privacy PolicyOpens in new window